CareDx (NASDAQ:CDNA – Get Free Report) will post its quarterly earnings results after the market closes on Wednesday, July 31st. Analysts expect CareDx to post earnings of ($0.13) per share for the quarter. CareDx has set its FY 2024 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.
CareDx (NASDAQ:CDNA – Get Free Report) last announced its earnings results on Thursday, May 9th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.18. The company had revenue of $72.05 million for the quarter, compared to analyst estimates of $63.63 million. CareDx had a negative return on equity of 55.08% and a negative net margin of 66.59%. On average, analysts expect CareDx to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
CareDx Stock Down 1.5 %
Shares of NASDAQ CDNA opened at $18.72 on Tuesday. The firm has a market cap of $974.94 million, a price-to-earnings ratio of -5.47 and a beta of 1.78. CareDx has a 52-week low of $4.80 and a 52-week high of $19.58. The business’s 50 day moving average is $15.55 and its two-hundred day moving average is $11.92.
Analysts Set New Price Targets
Check Out Our Latest Report on CDNA
About CareDx
CareDx, Inc engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.
Further Reading
- Five stocks we like better than CareDx
- Where to Find Earnings Call Transcripts
- Why This Manufacturer is Committing to a Massive Buyback Program
- Investing in Commodities: What Are They? How to Invest in Them
- Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
- What is a buyback in stocks? A comprehensive guide for investors
- Healthcare Stock Rides the Acute Services Phenomenon to New Highs
Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.